May 14, 2020 / 11:14 AM / 15 days ago

BRIEF-Bioxcel Therapeutics Announces Completion Of Patient Enrollment In Phase 3 Serenity Trials With Bxcl501

BioXcel Therapeutics Inc:

* BIOXCEL THERAPEUTICS ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE 3 SERENITY TRIALS WITH BXCL501 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below